These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 12648507)

  • 1. ABO incompatibility between donor and recipient and clinical outcomes in allogeneic stem cell transplantation.
    Goldman J; Liesveld J; Nichols D; Heal J; Blumberg N
    Leuk Res; 2003 Jun; 27(6):489-91. PubMed ID: 12648507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Donor-to-Recipient ABO Mismatch Does Not Impact Outcomes of Allogeneic Hematopoietic Cell Transplantation Regardless of Graft Source.
    Damodar S; Shanley R; MacMillan M; Ustun C; Weisdorf D
    Biol Blood Marrow Transplant; 2017 May; 23(5):795-804. PubMed ID: 28232088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ABO incompatibility as an adverse risk factor for survival after allogeneic bone marrow transplantation.
    Benjamin RJ; McGurk S; Ralston MS; Churchill WH; Antin JH
    Transfusion; 1999 Feb; 39(2):179-87. PubMed ID: 10037129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ABO compatibility and acute graft-versus-host disease following allogeneic bone marrow transplantation.
    Bacigalupo A; Van Lint MT; Occhini D; Margiocco M; Ferrari G; Pittaluga PA; Frassoni F; Peralvo J; Lercari G; Carubia F
    Transplantation; 1988 Jun; 45(6):1091-4. PubMed ID: 3289150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of ABO incompatibility on outcome after allogeneic peripheral blood stem cell transplantation.
    Kim JG; Sohn SK; Kim DH; Baek JH; Lee KB; Min WS; Kim CC; Lee MH; Lee JJ; Chung IJ; Kim HJ; Lee JW
    Bone Marrow Transplant; 2005 Mar; 35(5):489-95. PubMed ID: 15654350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of donor and recipient ABO incompatibility and antibody-associated complications after allogeneic stem cell transplantation with reduced-intensity conditioning.
    Watz E; Remberger M; Ringden O; Lundahl J; Ljungman P; Mattsson J; Wikman A; Uhlin M
    Biol Blood Marrow Transplant; 2014 Feb; 20(2):264-71. PubMed ID: 24274982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transplantation of ABO-incompatible bone marrow and peripheral blood stem cell components.
    Rowley SD; Liang PS; Ulz L
    Bone Marrow Transplant; 2000 Oct; 26(7):749-57. PubMed ID: 11042656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pure red-cell aplasia following major and bi-directional ABO-incompatible allogeneic stem-cell transplantation: recovery of donor-derived erythropoiesis after long-term treatment using different therapeutic strategies.
    Helbig G; Stella-Holowiecka B; Wojnar J; Krawczyk M; Krzemien S; Wojciechowska-Sadus M; Markiewicz M; Wylezol I; Kopera M; Holowiecki J
    Ann Hematol; 2007 Sep; 86(9):677-83. PubMed ID: 17486341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Consequences of ABO incompatibility in allogeneic hematopoietic stem cell transplantation.
    Stussi G; Muntwyler J; Passweg JR; Seebach L; Schanz U; Gmür J; Gratwohl A; Seebach JD
    Bone Marrow Transplant; 2002 Jul; 30(2):87-93. PubMed ID: 12132047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of ABO incompatibility in allogeneic hematopoietic stem cell transplantation.
    Ataca Atilla P; Akkus E; Atilla E; Gokmen N; Civriz Bozdag S; Kocak Toprak S; Kurt Yuksel M; Ozcan M; Demirer T; Ilhan O; Beksac M; Akan H; Arslan O; Topcuoglu P; Gurman G
    Transfus Clin Biol; 2020 Aug; 27(3):115-121. PubMed ID: 32659269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of ABO-incompatible donor on early and late outcome of hematopoietic stem cell transplantation.
    Ozkurt ZN; Yegin ZA; Yenicesu I; Aki SZ; Yagci M; Sucak GT
    Transplant Proc; 2009 Nov; 41(9):3851-8. PubMed ID: 19917400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical features and risk factors of pure red cell aplasia following major ABO-incompatible allogeneic hematopoietic stem cell transplantation.
    Zhu KE; Li JP; Zhang T; Zhong J; Chen J
    Hematology; 2007 Apr; 12(2):117-21. PubMed ID: 17454192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ABO incompatibility in mismatched unrelated donor allogeneic hematopoietic cell transplantation for acute myeloid leukemia: A report from the acute leukemia working party of the EBMT.
    Canaani J; Savani BN; Labopin M; Michallet M; Craddock C; Socié G; Volin L; Maertens JA; Crawley C; Blaise D; Ljungman PT; Cornelissen J; Russell N; Baron F; Gorin N; Esteve J; Ciceri F; Schmid C; Giebel S; Mohty M; Nagler A
    Am J Hematol; 2017 Aug; 92(8):789-796. PubMed ID: 28439910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of ABO mismatching on the outcomes of allogeneic related and unrelated blood and marrow stem cell transplantations for hematologic malignancies: IPD-based meta-analysis of cohort studies.
    Kanda J; Ichinohe T; Matsuo K; Benjamin RJ; Klumpp TR; Rozman P; Blumberg N; Mehta J; Sohn SK; Uchiyama T
    Transfusion; 2009 Apr; 49(4):624-35. PubMed ID: 19170998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of donor-recipient major ABO mismatch on allogeneic transplantation outcome according to stem cell source.
    Blin N; Traineau R; Houssin S; Peffault de Latour R; Petropoulou A; Robin M; Larghero J; Ribaud P; Socié G
    Biol Blood Marrow Transplant; 2010 Sep; 16(9):1315-23. PubMed ID: 20353831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of ABO incompatibility on patients' outcome after haploidentical hematopoietic stem cell transplantation for acute myeloid leukemia - a report from the Acute Leukemia Working Party of the EBMT.
    Canaani J; Savani BN; Labopin M; Huang XJ; Ciceri F; Arcese W; Tischer J; Koc Y; Bruno B; Gülbas Z; Blaise D; Maertens J; Ehninger G; Mohty M; Nagler A
    Haematologica; 2017 Jun; 102(6):1066-1074. PubMed ID: 28255020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does donor-recipient ABO incompatibility protect against relapse after allogeneic bone marrow transplantation in first remission acute myeloid leukemia?
    Mehta J; Powles R; Sirohi B; Treleaven J; Kulkarni S; Saso R; Tait D; Singhal S
    Bone Marrow Transplant; 2002 May; 29(10):853-9. PubMed ID: 12058235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of ABO-incompatibility on allogeneic hematopoietic stem cell transplantation].
    Bao L; Huang XJ; Liu KY; Xu LP; Chen H; Zhang YC; Chen YH; Han W; Lu DP
    Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Apr; 37(2):126-9. PubMed ID: 15841137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ABO blood group barrier in allogeneic bone marrow transplantation revisited.
    Seebach JD; Stussi G; Passweg JR; Loberiza FR; Gajewski JL; Keating A; Goerner M; Rowlings PA; Tiberghien P; Elfenbein GJ; Gale RP; van Rood JJ; Reddy V; Gluckman E; Bolwell BJ; Klumpp TR; Horowitz MM; Ringdén O; Barrett AJ;
    Biol Blood Marrow Transplant; 2005 Dec; 11(12):1006-13. PubMed ID: 16338623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pure red cell aplasia following ABO-incompatible allogeneic hematopoietic stem cell transplantation].
    Fan H; Jing Y; Li HH; Lu XC; Yu L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Apr; 16(2):364-7. PubMed ID: 18426666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.